Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.420
-0.020 (-0.58%)
At close: Jul 11, 2025, 4:00 PM
3.360
-0.060 (-1.75%)
After-hours: Jul 11, 2025, 5:41 PM EDT
Genelux Revenue
In the year 2024, Genelux had annual revenue of $8.00K, down -95.29%.
Revenue (ttm)
$8.00K
Revenue Growth
-95.29%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
127.94M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GNLX News
- 4 days ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire
- 2 months ago - Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 3 months ago - Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 months ago - Genelux Corporation Announces New Chief Financial Officer - GlobeNewsWire
- 7 months ago - Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - GlobeNewsWire
- 8 months ago - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 9 months ago - Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point - Seeking Alpha